Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interleukin-1 Blockade in Acute Myocardial Infarction to Prevent Heart Failure: The Virginia - Anakinra Remodeling Trial 4

NCT05177822 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT05177822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05177822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interleukin-1 Blockade in Acute Myocardial Infarction to Prevent Heart Failure: The Virginia - Anakinra Remodeling Trial 4
Lead sponsor
Virginia Commonwealth University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 24, 2022
Completion date
December 30, 2027
Enrollment
84 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure